Advertisement
Advertisement
CLOV
Clover Health Investments, Corp
3.55
USDSponsored
-0.05
-1.39%
May 22, 16:00 UTC -4
Closed
After-Market
3.55
0.00
+0.11%
CLOV Earnings Reports
Positive Surprise Ratio
CLOV beat 16 of 21 last estimates.
76%
Next Report
Date of Next Report
Aug 03, 2026
Estimate for Q2 26 (Revenue/ EPS)
$742.83M
/$0.03
Implied change from Q1 26 (Revenue/ EPS)
-0.85%
/-57.14%
Implied change from Q2 25 (Revenue/ EPS)
+55.53%
/-250.00%
Clover Health Investments, Corp earnings per share and revenue
On May 06, 2026, CLOV reported earnings of 0.07 USD per share (EPS) for Q1 26, beating the estimate of 0.03 USD, resulting in a 128.76% surprise. Revenue reached 749.19 million, compared to an expected 729.19 million, with a 2.74% difference. The market reacted with a +5.22% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 5 analysts forecast an EPS of 0.03 USD, with revenue projected to reach 742.83 million USD, implying an decrease of -57.14% EPS, and decrease of -0.85% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
CapsoVision, Inc. Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
-$0.13
Actual
-$0.15
Surprise
-12.02%
Nyxoah SA Ordinary Shares
Report Date
May 12, 2026 For Q1 26
Estimate
-$0.50
Actual
-$0.36
Surprise
+27.03%
MDxHealth SA Ordinary Shares
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.15
Actual
-$0.17
Surprise
-9.68%
Insight Molecular Diagnostics Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.26
Actual
-$0.12
Surprise
+55.01%
Neuraxis, Inc.
Report Date
May 12, 2026 For Q1 26
Estimate
-$0.19
Actual
-$0.18
Surprise
+7.12%
Health Catalyst, Inc Common Stock
Report Date
May 11, 2026 For Q1 26
Estimate
$0.01
Actual
$0.02
Surprise
+14.29%
Doximity, Inc.
Report Date
May 13, 2026 For Q4 26
Estimate
$0.28
Actual
$0.26
Surprise
-9.97%
Doximity, Inc.
Report Date
May 13, 2026 For Q1 26
Estimate
$0.28
Actual
$0.26
Surprise
-9.97%
Heartflow, Inc. Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
-$0.19
Actual
-$0.23
Surprise
-20.10%
Heartbeam, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.14
Actual
-$0.12
Surprise
+14.77%
FAQ
What were Clover Health Investments, Corp's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Clover Health Investments, Corp reported EPS of $0.07, beating estimates by 128.76%, and revenue of $749.19M, 2.74% above expectations.
How did the market react to Clover Health Investments, Corp's Q1 2026 earnings?
The stock price moved up 5.22%, changed from $2.68 before the earnings release to $2.82 the day after.
When is Clover Health Investments, Corp expected to report next?
The next earning report is scheduled for Aug 03, 2026.
What are the forecasts for Clover Health Investments, Corp's next earnings report?
Based on 5
analysts, Clover Health Investments, Corp is expected to report EPS of $0.03 and revenue of $742.83M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement